Oval wants to promote autoinjector platforms that are actually patient-centric.
Oval, a company founded in 2009 by Matthew Young, has a different strategy, developing from the outside in to meet all patient demands. Our team’s breadth of knowledge enables us to provide partners and clients the finest solutions.
With a quality system that complies with BS EN 13485:2016, our company has evolved to meet contemporary quality requirements. We also follow the principles set out in the Medical Device Directive 93/42/EEC, FDA 21 CFR Pt. 820, and ANSI/AAMI HE75.
SMC Ltd., a multinational contract producer of completed medical equipment, purchased Oval in December 2016. Oval’s design and development skills and SMC’s years of expertise in the global production of single
